Ann: Investor Presentation, page-75

The sp may go either way next week depending on sentiment or news .
As mentioned CEO returning from a trip next week which in my opinion would of been important otherwise rescheduling trip after EXPO would of been much more appropriate you would think . Time will tell .

I have pasted below a post from UmiTrader ( 1/6/17 ) which I especially liked , hope you don't mind UmiTrader .

Notwithstanding the dementia App, the market for pain management in kids is larger than the diagnosis market in kids with respiratory disease, clearly, because every kid has pain but not every kid has respiratory disease, so I don't agree with that. Furthermore, EPT is closer to commercialisation than RAP. Yet while there are some similarities in the delivery (using a smart phone) of both products, there are differences in what the Apps do - RAP is a diagnostic tool, EPT is a pain management tool. RAP could save lives while EPT could improve life quality.

In June we expect technical file completion for TGA and CE Mark self certification as a Class 1 medical device.
We also expect implementation studies with Bupa in Victoria using the beta version of the App to commence.

Other news possible (not in the official timetable) are patent news, nViso license and the library of kids facial expressions for development of the kids App.